Related Experiment Video
Updated: Jul 6, 2026

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
Published on: February 22, 2019
[Rational pharmacotherapeutic pain treatment in seronegative spondyloarthropathies]
Jadranka Morović-Vergles1, Simeon Grazio
1Zavod za klinicku imunollogiju i reumatologiju, Klinika za unutarnje bolesti, KIinic&ka bolnica "Dubrava" , Avenija G. Suska 6, 10000 Zagreb.
Abstract:
The aims of management in seronegative spondiloarthritides are to control pain and inflammation, maintain optimal mobility of spine and peripheral joints, restoration and preservation of functional ability, prevent contractures and deformities. Non-steroidal anti-inflammatory drugs are the basis of drug treatment. Numerous non-steroidal anti-inflammatory drugs have been shown to reduce pain and inflammation. Apart from non-steroidal anti-inflammatory drugs, in order to control the pain pure analgesics and weak opioids are the most often used drugs. In this paper is discussed use of these drugs in patients with seronegative spondyloarthritides.
Related Concept Videos
Analgesia and Pain Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Nociception
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
